Find therapies in clinical trials near you – page 144

Study on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Study on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Study on Adding Nivolumab to Cisplatin and Radiotherapy for High-Risk Patients with Head and Neck Squamous Cell Carcinoma

Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

Study on the Effects of ARO-MUC5AC Inhalation Solution for Patients with Asthma and COPD

Study Comparing Savolitinib and Osimertinib with Chemotherapy for Advanced Non-Small Cell Lung Cancer in Patients with EGFR Mutation and MET Overexpression

Study of Trastuzumab Deruxtecan for Patients with Metastatic or Unresectable HER2 Expressing Tumors

Study on the Safety and Effects of AMT-130 for Adults with Early Huntington's Disease

Study on the Safety and Effects of AMT-130 for Adults with Early Huntington's Disease

Access to Mepolizumab for Patients with Hypereosinophilic Syndrome

Access to Mepolizumab for Patients with Hypereosinophilic Syndrome

Study comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma

Study comparing iberdomide, daratumumab and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension